Surgery for cancer that has spread to the liver
Part of Cancer clinical trials.
This study looks at people who have cancer that started elsewhere in the body and spread to the liver, and who are having surgery to remove the liver tumors. The goal is to learn more about their outcomes and recovery after this type of surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of cancer that has spread to the liver, but the cancer did not start in the colon or rectum.
- You must be having (or have had) an operation to remove the liver tumor(s).
- You must be well enough overall (not in very poor health) and able to attend follow-up visits.
- If you've had only needle-based or other non-surgical liver treatments (without surgery), you won't be eligible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a local (targeted) approach for breast cancer that has spread to the liver. It looks at whether treating liver metastases with planned liver surgery, along with standard cancer treatment before and after, can improve outcomes.
This study compares two different types of liver surgery for people with colorectal cancer that has spread to the liver and who have specific genetic changes or a right-sided primary tumor. You will be randomly assigned to one surgery type, and researchers will track how well you do over time to see if one approach is better.
This study looks at how breast cancer that has spread to the liver responds to different treatments, including surgery and medicines. The goal is to learn which approach works best for patients with this condition.
This study collects health information from patients with cancer that has spread to the liver. Researchers will track your medical history and outcomes to better understand how metastatic liver cancer develops and progresses.
This study looks at MRI scans and tissue samples from people with colorectal cancer that has spread to the liver. The goal is to find patterns that might predict whether the cancer will come back after surgery, which could help guide future treatment.
This Phase 3 trial studies a treatment approach for people whose colorectal cancer has come back in the liver within 12 months and can be treated with local procedures. It aims to see whether the study treatment can improve outcomes compared with standard care for people with a limited number of liver tumors.
Hear when a new Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.